25338 Federal Register / Vol. 65, No. 84 / Monday, May 1, 2000 / Notices

future filing, of a food additive petition

(FAP 8A4588) proposing that the food

additive regulations be amended to

provide for the safe use of completely

hydrolyzed copolymer of acrylonitrile

and trivinylcyclohexane ion-exchange

resin for use in treating potable water

and aqueous, acidic, and alcoholic

foods.

FOR FURTHER INFORMATION CONTACT:

Parvin M. Yasaei, Center for Food Safety

and Applied Nutrition (HFS–215), Food

and Drug Administration, 200 C St. SW.,

Washington, DC 20204, 202–418–3023.

SUPPLEMENTARY INFORMATION: In a notice

published in the Federal Register of

April 1, 1998 (63 FR 15851), FDA

announced that a food additive petition

(FAP 8A4588) had been filed by Rohm

and Haas Co., 5000 Richmond St.,

Philadelphia, PA 19137. The petition

proposed to amend the food additive

regulations in § 173.25 Ion-exchange

resins (21 CFR 173.25) to provide for the

safe use of completely hydrolyzed

copolymer of acrylonitrile and

trivinylcyclohexane ion-exchange resin

for use in treating potable water and

aqueous, acidic, and alcoholic foods.

Rohm and Haas Co. has now withdrawn

the petition without prejudice to a

future filing (21 CFR 171.7).

Dated: March 24, 2000.

Laura M. Tarantino,

Acting Director, Office of Premarket

Approval, Center for Food Safety and Applied

Nutrition.

[FR Doc. 00–10689 Filed 4–28–00; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Submission for OMB Review;

Comment Request: The Framingham

Study

SUMMARY: Under the provisions of

section 3507(a)(1)(D) of the Paperwork

Reduction Act of 1995, the National

Heart, Lung, and Blood Institute

(NHLBI), the National Institutes of

Health (NIH) has submitted to the Office

of Management and Budget (OMB) a

request for review and approval of the

information collection listed below.

This proposed information collection

was previously published in the Federal

Register on December 30, 1999, page

73564 and allowed 60-days for public

comment. No public comments were

received. The purpose of this notice is

to allow an additional 30 days for public

comment. The National Institutes of

Health may not conduct or sponsor, and

the respondent is not required to

respond to, an information collection

that has been extended, revised, or

implemented on or after October 1,

1995, unless it displays a currently valid

OMB control number.

Proposed Collection

Title: The Framingham Study. Type of

Information Collection Request:

Revision of a currently approved

collection (OMB No. 0925–0216). Need

and Use of Information Collection: This

project involves physical examination

and testing of the surviving members of

the original Framingham Study cohort

and the surviving members of the

offspring cohort. Investigators will

contact doctors, hospitals, and nursing

homes to ascertain participants’

cardiovascular events occurring outside

the study clinic. Information gathered

will be used to further describe the risk

factors, occurrence rates, and

consequences of cardiovascular disease

in middle aged and older men and

women. Frequency of Response: The

cohort participants respond every two

years; the offspring participants respond

every four years. Affected Public:

Individuals or households; Businesses

or other for-profit; Small businesses or

organizations. Type of Respondents:

Middle aged and elderly adults; doctors

and staff of hospitals and nursing

homes. The annual reporting burden is

as follows: Estimated Number of

Respondents: 2,865; Estimated Number

of Responses per Respondent: 3.398;

Average Burden Hours Per Response:

0.6321; and Estimated Total Annual

Burden Hours Requested: 6,154. The

annualized cost to respondents is

estimated at $80,485 assuming

respondents time at the rate of $10 per

hour and physician/medical staff time at

the rate of $55 per hour. There are no

Capital Costs to report. There are no

Operating or Maintenance Costs to

report.

ESTIMATE OF HOUR BURDEN

Type of respondents

Estimated

number of

respondents

Estimated

number of

responses per

respondent

Average

burden hours

per response

Estimated total

annual burden

hours

requested

Framingham Original Cohort ........................................................................... 340 3.912 0.3496 465

Framingham Offspring Cohort ......................................................................... 1,267 5.642 0.7300 5,218

Physician, hospital, nursing home staff ........................................................... 629 1.000 0.6700 421

Framingham next-of-kin ................................................................................... 629 1.000 0.0800 50

Total .......................................................................................................... 2,865 3.398 0.6321 6,154

Request for Comments

Written comments and/or suggestions

from the public and affected agencies

are invited on one or more of the

following points: (1) Whether the

proposed collection of information is

necessary for the proper performance of

the function of the agency, including

whether the information will have

practical utility; (2) The accuracy of the

agency’s estimate of the burden of the

proposed collection of information,

including the validity of methodology

and assumptions used; (3) Ways to

enhance the quality, utility, and clarity

of the information to be collected; and

(4) Ways to minimize the burden of the

collection of information on those who

are to respond, including the use of

appropriate automated, electronic,

mechanical, or other technological

collection techniques or other forms of

information technology.

Direct Comments to OMB

Written comments and/or suggestions

regarding the item(s) contained in this

notice, especially regarding the

estimated public burden and associated

response time, should be directed to the:

Office of Management and Budget,

Office of Regulatory Affairs, New

Executive Office Building, Room 10235,

Washington, DC 20503, Attention: Desk

Officer for NIH. To request more

information on the proposed project or

to obtain a copy of the data collection

plans and instruments, contact: Dr. Paul

Sorlie, Project Officer, NIH, NHLBI,

6701 Rockledge Drive, MSC 7934,

Bethesda, MD 20892–7934, or call nonVerDate 27<APR>2000 18:22 Apr 28, 2000 Jkt 190000 PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 E:\FR\FM\01MYN1.SGM pfrm08 PsN: 01MYN1
Federal Register / Vol. 65, No. 84 / Monday, May 1, 2000 / Notices 25339

toll-free number (301) 435–0456 or Email your request, including your

address to: SorlieP@nih.gov.

Comments Due Date

Comments regarding this information

collection are best assured of having

their full effect it received on or before

June 30, 2000.

Dated: April 20, 2000.

Peter Savage,

Acting Director, Division of Epidemiology and

Clinical Applications, National Heart, Lung,

and Blood Institute.

[FR Doc. 00–10793 Filed 4–28–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Fogarty International Center; Notice of

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

Fogarty International Center Advisory

Board.

The meeting will be open to the

public as indicated below, with

attendance limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications

and/or contract proposals and the

discussions could disclose confidential

trade secrets or commercial property

such as patentable material, and

personal information concerning

individuals associated with the grant

applications and/or contract proposals,

the disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Fogarty International

Center Advisory Board.

Date: May 16, 2000.

Open: 8:30 a.m. to 12 p.m.

Agenda: Report of the Director, plans for

Fogarty International Center in-house

research activities, International

Epidemiology, Science Policy, and Putting

Mental Health on the International Agenda:

Role of the FIC and NIH.

Place: Lawton Chiles International House,

16 Center Drive, (Building 16), Bethesda, MD

20892.

Closed: 1 p.m. to adjournment.

Agenda: To review and evaluate grant

applications and/or proposals.

Place: Lawton Chiles International House,

16 Center Drive, (Building 16), Bethesda, MD

20892.

Contact Person: Irene W. Edwards,

Information Officer, Fogarty International

Center, National Institutes of Health,

Building 31, Room B2C08, 31 Center Drive

MSC 2220, Bethesda, MD 20892, 301–496–

2075.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.106, Minority International

Research Training Grant in the Biomedical

and Behavioral Sciences; 93.154, Special

International Postdoctoral Research Program

in Acquired Immunodeficiency Syndrome;

93.168, International Cooperative

Biodiversity Groups Program; 93.934, Fogarty

International Research Collaboration Award;

93.989, Senior International Fellowship

Awards Program, National Institutes of

Health, HHS)

Dated: April 21, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–10786 Filed 4–28–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Eye Institute; Notice of

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

Board of Scientific Counselors, National

Eye Institute.

The meeting will be open to the

public as indicated below, with

attendance limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

The meeting will be closed to the

public as indicated below in accordance

with the provisions set forth in section

552b(c)(6), Title 5 U.S.C., as amended

for the review, discussion and

evaluation of individual intramural

programs and projects conducted by the

National Eye Institute, including

consideration of personnel

qualifications and performance, and the

competence of individual investigators,

the disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Board of Scientific

Counselors, National Eye Institute.

Date: June 5–6, 2000.

Open: June 5, 2000, 9 a.m. to 10 a.m.

Agenda: Opening remarks by the Director,

Intramural Research Program, on matters

concerning the intramural program of the

NEI.

Place: Building 10, Room 10B16, Bethesda,

MD 20892.

Closed: June 5, 2000, 10 a.m. to 5 p.m.

Agenda: To review and evaluate personal

qualifications and performance, and

competence of individual investigators.

Place: Building 10, Room 10B16, Bethesda,

MD 20892.

Closed: June 6, 2000, 9 a.m. to 5 p.m.

Agenda: To review and evaluate personal

qualifications and performance, and

competence of individual investigators.

Place: Building 10, Room 10B16, Bethesda,

MD 20892.

Contact Person: Robert B. Nussenblatt, MD,

Director, Intramural Research Program,

National Eye Institute, National Institutes of

Health, PHS, DHHS, Bethesda, MD 20892,

301–496–3123.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.867, Vision Research,

National Institutes of Health, HHS)

Dated: April 21, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–10785 Filed 4–28–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Arthritis and

Musculoskeletal and Skin Diseases;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Arthritis and Musculoskeletal and Skin

Diseases Special Emphasis Panel.

Date: May 22, 2000.

Time: 8:30 a.m. to 4:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: Ramada Inn Rockville, 1775

Rockville Pike, Rockville, MD 20852.

Contact Person: Aftab A. Ansari, Scientific

Review Administrator, National Institutes of